Azacitidine and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Azacitidine (azacitidine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Venclexta, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Azacitidine. It is created by eHealthMe based on reports of 17,184 people who have side effects when taking Azacitidine from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,956 drugs and 2,937 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jul, 15, 2026

17,184 people reported to have side effects when taking Azacitidine.
Among them, 53 people (0.31%) have Hyperkalemia.

Among these 53 people:

How long have people been on Azacitidine when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Azacitidine? *

female: 27.45 %
male: 72.55 %

What is the age of people who have Hyperkalemia when taking Azacitidine? *

What are other drugs people take besides Azacitidine? *

What are other side effects people have besides Hyperkalemia? *

Tumor Lysis Syndrome: 26 people, 49.06%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 12 people, 22.64%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 20.75%
Dyspnea (difficult or laboured breathing): 11 people, 20.75%
Thrombocytopenia (decrease of platelets in blood): 10 people, 18.87%
Fever: 10 people, 18.87%
Febrile Neutropenia (fever with reduced white blood cells): 8 people, 15.09%
Constipation: 8 people, 15.09%
White Blood Cell Count Decreased: 7 people, 13.21%
Anaemia (lack of blood): 7 people, 13.21%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 30 people, 56.60%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 18 people, 33.96%
Hepatitis B: 6 people, 11.32%
High Blood Pressure: 6 people, 11.32%
Tumor Lysis Syndrome: 6 people, 11.32%
Pneumonia: 5 people, 9.43%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 5 people, 9.43%
Insomnia (sleeplessness): 4 people, 7.55%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 4 people, 7.55%
Pain: 4 people, 7.55%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azacitidine:

Azacitidine (17,184 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Azacitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,956 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,937 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azacitidine (the active ingredients of Azacitidine) and Azacitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.